These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 2903201
1. Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonist. Woodward DF, Novack GD, Williams LS, Nieves AL, Potter DE. J Ocul Pharmacol; 1987; 3(1):11-5. PubMed ID: 2903201 [Abstract] [Full Text] [Related]
3. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects. Nathanson JA. Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744 [Abstract] [Full Text] [Related]
4. Pharmacological characterization of beta-adrenoceptor subtype involvement in the ocular hypotensive response to beta-adrenergic stimulation. Woodward DF, Chen J, Padillo E, Ruiz G. Exp Eye Res; 1986 Jul; 43(1):61-75. PubMed ID: 2874044 [Abstract] [Full Text] [Related]
5. Ocular levobunolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Gonzalez JP, Clissold SP. Drugs; 1987 Dec; 34(6):648-61. PubMed ID: 2892662 [Abstract] [Full Text] [Related]
19. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits. Acheampong AA, Breau A, Shackleton M, Luo W, Lam S, Tang-Liu DD. J Ocul Pharmacol Ther; 1995 Apr; 11(4):489-502. PubMed ID: 8574812 [Abstract] [Full Text] [Related]
20. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit. Vareilles P, Silverstone D, Plazonnet B, Le Douarec JC, Sears ML, Stone CA. Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]